Inceptor Bio to Present at CAR-TCR Summit in Boston

Morrisville, NC – Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the presentation at the CAR-TCR Summit in Boston (8th CAR-TCR Summit | Boston, MA (

Presenter: Sumiti Jain, PhD, VP of R&D
Title: Overcoming Resistance & the Tumor Microenvironment with CAR-Macrophage Therapies
Date: August 29th
Time: 11am EST

About Inceptor Bio

Founded in 2020, Inceptor Bio is a biotechnology company strategically advancing a pipeline of diversified cell therapies in oncology. Inceptor is developing CAR-T, CAR-M, & CAR-NK products engineered for optimal efficacy against solid tumors. Additional information about Inceptor Bio is available at